Guangdong Kanghua Healthcare Co., Ltd.

SEHK:3689 Stock Report

Market Cap: HK$912.9m

Guangdong Kanghua Healthcare Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Guangdong Kanghua Healthcare.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth15.2%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now

Jun 19
Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now

Does Guangdong Kanghua Healthcare (HKG:3689) Deserve A Spot On Your Watchlist?

Jun 10
Does Guangdong Kanghua Healthcare (HKG:3689) Deserve A Spot On Your Watchlist?

Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

May 22
Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Nov 28
Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

May 09
Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Feb 02
Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Here's Why Guangdong Kanghua Healthcare (HKG:3689) Can Manage Its Debt Responsibly

Nov 08
Here's Why Guangdong Kanghua Healthcare (HKG:3689) Can Manage Its Debt Responsibly

Some Investors May Be Worried About Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

Sep 06
Some Investors May Be Worried About Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

Investors Could Be Concerned With Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

May 31
Investors Could Be Concerned With Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

Jan 25
Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Sep 21
Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Is Guangdong Kanghua Healthcare (HKG:3689) Using Too Much Debt?

May 03
Is Guangdong Kanghua Healthcare (HKG:3689) Using Too Much Debt?

Do Insiders Own Lots Of Shares In Guangdong Kanghua Healthcare Co., Ltd. (HKG:3689)?

Feb 04
Do Insiders Own Lots Of Shares In Guangdong Kanghua Healthcare Co., Ltd. (HKG:3689)?

Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque

Dec 14
Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Guangdong Kanghua Healthcare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SEHK:3689 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20232,04212173204N/A
9/30/20232,00611876219N/A
6/30/20231,97011680234N/A
3/31/20231,9088993227N/A
12/31/20221,84660106221N/A
9/30/20221,8955997225N/A
6/30/20221,9455987228N/A
3/31/20221,95076125281N/A
12/31/20211,95494162333N/A
9/30/20211,905103198369N/A
6/30/20211,856112233405N/A
3/31/20211,80043173340N/A
12/31/20201,745-25113275N/A
9/30/20201,774-63-8167N/A
6/30/20201,802-100-12859N/A
3/31/20201,879-13-12478N/A
12/31/20191,95674-12198N/A
9/30/20191,885112-29153N/A
6/30/20191,81515062207N/A
3/31/20191,72715974192N/A
12/31/20181,63916887177N/A
9/30/20181,56616973181N/A
6/30/20181,49217059185N/A
3/31/20181,44116352200N/A
12/31/20171,38915744214N/A
9/30/20171,338153N/A189N/A
6/30/20171,287149N/A163N/A
3/31/20171,264145N/A159N/A
12/31/20161,240141N/A155N/A
12/31/20151,064119N/A199N/A
12/31/2014985102N/A206N/A
12/31/2013859107N/A214N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 3689's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if 3689's earnings are forecast to grow faster than the Hong Kong market

High Growth Earnings: Insufficient data to determine if 3689's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 3689's revenue is forecast to grow faster than the Hong Kong market.

High Growth Revenue: Insufficient data to determine if 3689's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 3689's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.